Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02379949 · ClinicalTrials.gov registry record · NA

Virtual Reality Exposure Therapy for the Treatment of Social Phobia

A NA study of Social Anxiety Disorder, sponsored by Georgia State University.

Completed
Registry status
NA
Development phase
97
Enrollment target
1
Study location

NCT02379949 is a NA study of Social Anxiety Disorder that has completed, run by Georgia State University. The registered enrollment target is 97 participants, below the 157-participant average among 32 other Social Anxiety Disorder trials with a reported enrollment target (38% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02379949, a NA study of Social Anxiety Disorder, has completed, sponsored by Georgia State University.

COMPLETED
Registry status
NA
Development phase
97 participants
Enrollment target
1
Study location

Study Summary

This randomized clinical trial compares virtual reality exposure therapy to exposure group therapy to a waiting list control group.

Conditions Studied

Interventions

  • BEHAVIORAL Virtual Reality Exposure Therapy
  • BEHAVIORAL Exposure Group Therapy

Study Locations (1)

Georgia

  • Georgia State University - Atlanta

Trial Details

FieldValue
Enrollment Target 97 participants
Start Date 2004-08
Est. Completion 2007-08
Phase NA

Sponsor

Georgia State University

45 total trials

What the Registry Record Tells You About NCT02379949

The ClinicalTrials.gov registry entry for NCT02379949 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 97 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 157-participant average among 32 other Social Anxiety Disorder trials with a reported enrollment target (38% lower). The listed sponsor is Georgia State University, which has 45 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Social Anxiety Disorder appearing as the primary indexed condition, and to 2 interventions - of which Virtual Reality Exposure Therapy is the first listed.

NCT02379949 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT02379949 about?

NCT02379949 is a clinical study titled "Virtual Reality Exposure Therapy for the Treatment of Social Phobia". This randomized clinical trial compares virtual reality exposure therapy to exposure group therapy to a waiting list control group.

What is the current status of trial NCT02379949?

This trial is currently completed. It is a NA study. The enrollment target is 97 participants. The study started on 2004-08. Estimated completion is 2007-08.

What conditions does trial NCT02379949 study?

This clinical trial studies the following conditions: Social Anxiety Disorder.

What interventions are being tested in trial NCT02379949?

The interventions under investigation include: Virtual Reality Exposure Therapy (BEHAVIORAL), Exposure Group Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT02379949?

This trial is sponsored by Georgia State University, which has 45 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02379949 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Social Anxiety Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.